Unveiling the potential application of intraoperative brain smear for brain tumor diagnosis in low-middle-income countries: A comprehensive systematic review.
Brain tumors
Intraoperative brain smear
Low- and middle-income countries
Journal
Surgical neurology international
ISSN: 2229-5097
Titre abrégé: Surg Neurol Int
Pays: United States
ID NLM: 101535836
Informations de publication
Date de publication:
2023
2023
Historique:
received:
09
06
2023
accepted:
15
08
2023
medline:
9
10
2023
pubmed:
9
10
2023
entrez:
9
10
2023
Statut:
epublish
Résumé
Immediate intraoperative histopathological examination of tumor tissue is indispensable for a neurosurgeon to track surgical resection. A brain smear is a simple, rapid, and cost-effective technique, particularly important in the diagnosis of brain tumors. The study aims to determine the effectiveness of intraoperative brain smear in the diagnosis of brain tumors in low- and middle-income countries (LMICs), while also evaluating its sensitivity, specificity, positive predictive value (PPV), negative predictive value (NPV), and overall accuracy. A comprehensive search of the literature was conducted using PubMed, Scopus, and Google Scholar. The retrieved articles were independently screened by two reviewers. The data was extracted, processed, and organized using Microsoft Excel. A total of 59 out of 553 articles screened were included in the final analysis. The sensitivity and specificity of the intraoperative smear of brain tumors were found to be over 90% in most studies. The PPV was consistently above 90% in 11 studies, reaching 100% in one study and the NPV varied, ranging from 63% to 100%, and the accuracy was found to be >80% in most studies. One recurrent theme in the majority of the included studies was that an intraoperative brain smear is a cost-effective, quick, accessible, and accurate method of diagnosing brain tumors, requiring minimal training and infrastructure. Intraoperative brain smear is a simple, rapid, cost-effective, and highly sensitive diagnostic modality for brain tumors. It can be a viable and accessible alternative to more traditional methods such as frozen sections and can be incorporated into neurosurgical practice in LMICs as a reliable and efficient diagnostic tool.
Sections du résumé
Background
UNASSIGNED
Immediate intraoperative histopathological examination of tumor tissue is indispensable for a neurosurgeon to track surgical resection. A brain smear is a simple, rapid, and cost-effective technique, particularly important in the diagnosis of brain tumors. The study aims to determine the effectiveness of intraoperative brain smear in the diagnosis of brain tumors in low- and middle-income countries (LMICs), while also evaluating its sensitivity, specificity, positive predictive value (PPV), negative predictive value (NPV), and overall accuracy.
Methods
UNASSIGNED
A comprehensive search of the literature was conducted using PubMed, Scopus, and Google Scholar. The retrieved articles were independently screened by two reviewers. The data was extracted, processed, and organized using Microsoft Excel.
Results
UNASSIGNED
A total of 59 out of 553 articles screened were included in the final analysis. The sensitivity and specificity of the intraoperative smear of brain tumors were found to be over 90% in most studies. The PPV was consistently above 90% in 11 studies, reaching 100% in one study and the NPV varied, ranging from 63% to 100%, and the accuracy was found to be >80% in most studies. One recurrent theme in the majority of the included studies was that an intraoperative brain smear is a cost-effective, quick, accessible, and accurate method of diagnosing brain tumors, requiring minimal training and infrastructure.
Conclusion
UNASSIGNED
Intraoperative brain smear is a simple, rapid, cost-effective, and highly sensitive diagnostic modality for brain tumors. It can be a viable and accessible alternative to more traditional methods such as frozen sections and can be incorporated into neurosurgical practice in LMICs as a reliable and efficient diagnostic tool.
Identifiants
pubmed: 37810296
doi: 10.25259/SNI_491_2023
pii: 10.25259/SNI_491_2023
pmc: PMC10559528
doi:
Types de publication
Journal Article
Review
Langues
eng
Pagination
325Informations de copyright
Copyright: © 2023 Surgical Neurology International.
Déclaration de conflit d'intérêts
There are no conflicts of interest.
Références
Asian Pac J Cancer Prev. 2020 Oct 01;21(10):3085-3091
pubmed: 33112571
J Neurosurg. 1973 Jul;39(1):82-8
pubmed: 4717143
Indian J Pathol Microbiol. 2008 Oct-Dec;51(4):469-73
pubmed: 19008568
Indian J Pathol Microbiol. 2006 Oct;49(4):483-6
pubmed: 17183833
Acta Cytol. 1998 Sep-Oct;42(5):1149-54
pubmed: 9755673
J Cytol. 2015 Jul-Sep;32(3):153-8
pubmed: 26729974
J Clin Diagn Res. 2014 Oct;8(10):FC09-12
pubmed: 25478346
Surg Neurol. 1986 Aug;26(2):176-82
pubmed: 3726744
Neurol India. 2022 Mar-Apr;70(2):714-720
pubmed: 35532645
Ann Clin Lab Sci. 2001 Apr;31(2):133-9
pubmed: 11337901
Diagn Cytopathol. 2019 May;47(5):428-433
pubmed: 30569601
Cytopathology. 2007 Oct;18(5):300-8
pubmed: 17883691
Asian Pac J Cancer Prev. 2011;12(6):1435-7
pubmed: 22126477
J Cytol. 2022 Jan-Mar;39(1):1-8
pubmed: 35341115
Epidemiology. 1996 Mar;7(2):199-202
pubmed: 8834562
Arch Pathol Lab Med. 1997 Jun;121(6):559-67
pubmed: 9199619
Cytopathology. 2022 Jan;33(1):107-113
pubmed: 34390057
Endocr Pathol. 2019 Sep;30(3):180-188
pubmed: 31228001
Asian Pac J Cancer Prev. 2011;12(7):1693-6
pubmed: 22126546
Trop Doct. 2004 Oct;34(4):223-5
pubmed: 15510948
J Cytol. 2016 Oct-Dec;33(4):205-209
pubmed: 28028335
J Cytol. 2016 Apr-Jun;33(2):93-7
pubmed: 27279685
Diagn Cytopathol. 2015 Mar;43(3):195-201
pubmed: 25088568
Malays J Med Sci. 2006 Jan;13(1):4-12
pubmed: 22589584
Cytopathology. 2022 Mar;33(2):196-205
pubmed: 34747537
Eur J Epidemiol. 2010 Sep;25(9):603-5
pubmed: 20652370
Neurol India. 2009 Jul-Aug;57(4):464-8
pubmed: 19770549
JAMA. 2018 Jan 23;319(4):388-396
pubmed: 29362800
Acta Neurol Scand. 2003 Sep;108(3):153-6
pubmed: 12911456
Open Med. 2009;3(3):e123-30
pubmed: 21603045
Ann Diagn Pathol. 2009 Dec;13(6):359-66
pubmed: 19917470
Diagn Cytopathol. 2012 Feb;40(2):104-12
pubmed: 22246925
Lancet Oncol. 2015 Sep;16(11):1193-224
pubmed: 26427363
Acta Neuropathol. 2007 Aug;114(2):97-109
pubmed: 17618441
Acta Cytol. 2019;63(3):224-232
pubmed: 30982032
Iran J Med Sci. 2012 Jun;37(2):105-11
pubmed: 23115439
Acta Cytol. 2002 Jul-Aug;46(4):667-74
pubmed: 12146028
Acta Cytol. 2018;62(1):44-53
pubmed: 28977789
Cancer. 2008 Oct 1;113(7 Suppl):1953-68
pubmed: 18798534
J Neurosci Rural Pract. 2017 Apr-Jun;8(2):221-224
pubmed: 28479796
J Cytol. 2017 Oct-Dec;34(4):217-220
pubmed: 29118478
Kathmandu Univ Med J (KUMJ). 2008 Oct-Dec;6(24):453-7
pubmed: 19483425
J Pathol Transl Med. 2019 Mar;53(2):104-111
pubmed: 30636391
Indian J Med Paediatr Oncol. 2017 Jul-Sep;38(3):296-301
pubmed: 29200677
Am J Pathol. 1930 Sep;6(5):541-552.7
pubmed: 19969928
Cytopathology. 2012 Oct;23(5):308-14
pubmed: 21838720
J Cytol. 2013 Jul;30(3):179-84
pubmed: 24130410
J Lab Physicians. 2022 Aug 17;14(4):384-393
pubmed: 36531541
J Cytol. 2010 Jul;27(3):81-5
pubmed: 21187881
Diagn Cytopathol. 2012 Oct;40(10):865-70
pubmed: 21630481
Lancet Neurol. 2019 Apr;18(4):376-393
pubmed: 30797715
J Oral Maxillofac Pathol. 2018 Sep-Dec;22(3):443
pubmed: 30651699